Gotowe bibliografie tematyczne / Oral tolerance

Gotowa bibliografia na temat „Oral tolerance”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 6 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Spis treści

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Oral tolerance”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Oral tolerance"

1

Faria, Ana M. C., i Howard L. Weiner. "Oral tolerance". Immunological Reviews 206, nr 1 (sierpień 2005): 232–59. http://dx.doi.org/10.1111/j.0105-2896.2005.00280.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

SMITH, K. M., A. D. EATON, L. M. FINLAYSON i P. GARSIDE. "Oral Tolerance". American Journal of Respiratory and Critical Care Medicine 162, supplement_3 (październik 2000): S175—S178. http://dx.doi.org/10.1164/ajrccm.162.supplement_3.15tac7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Weiner, Howard L., Andre Pires da Cunha, Francisco Quintana i Henry Wu. "Oral tolerance". Immunological Reviews 241, nr 1 (13.04.2011): 241–59. http://dx.doi.org/10.1111/j.1600-065x.2011.01017.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Weiner, H. L. "Oral tolerance." Proceedings of the National Academy of Sciences 91, nr 23 (8.11.1994): 10762–65. http://dx.doi.org/10.1073/pnas.91.23.10762.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Wu, Henry Yim, i Howard L. Weiner. "Oral Tolerance". Immunologic Research 28, nr 3 (2003): 265–84. http://dx.doi.org/10.1385/ir:28:3:265.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Garside, P., i A. McI Mowat. "Oral tolerance". Seminars in Immunology 13, nr 3 (czerwiec 2001): 177–85. http://dx.doi.org/10.1006/smim.2001.0310.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Moreau, Caroline, James Trussell, Fabien Gilbert, Nathalie Bajos i Jean Bouyer. "Oral Contraceptive Tolerance". Obstetrics & Gynecology 109, nr 6 (czerwiec 2007): 1277–85. http://dx.doi.org/10.1097/01.aog.0000260956.61835.6d.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Garside, Paul, i Allan Mcl Mowat. "Mechanisms of Oral Tolerance". Critical Reviews™ in Immunology 17, nr 2 (1997): 119–37. http://dx.doi.org/10.1615/critrevimmunol.v17.i2.10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Eiks, M. L. "Oral Glucose Tolerance Tests". Diabetes Care 19, nr 3 (1.03.1996): 271. http://dx.doi.org/10.2337/diacare.19.3.271a.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Margalit, Maya, i Yaron Ilan. "Oral Tolerance for IBD". American Journal of Gastroenterology 101, nr 12 (grudzień 2006): 2890–91. http://dx.doi.org/10.1111/j.1572-0241.2006.00867_9.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Oral tolerance"

1

Boulton-Jones, John Robert. "Oral tolerance to soluble protein antigens in humans". Thesis, University of Edinburgh, 2001. http://hdl.handle.net/1842/22766.

Pełny tekst źródła
Streszczenie:
In this thesis, a protocol to demonstrate oral tolerance is described. Keyhole limpet haemocyanin (KLH), a neo-antigen, was used to demonstrate low dose tolerance. A control group was immunised with KLH and the subsequent immune response was assessed by delayed type hypersensitivity responses, in vitro lymphocyte proliferation to KLH and anti-KLH IgG and IgA production. Another group of volunteers was pre-fed a course of KLH prior to receiving the same immunisation schedule. The same measures of the immune response used in the control group were assessed and any differences were attributed to oral tolerance. A third group of volunteers was immunised with ovalbumin (OVA) and the immune response was measured. OVA is a common dietary protein and therefore was used to assess oral tolerance to extended courses of feeding. The group fed 50mg of KLH for 10 days demonstrated reduced DTH responses but without significant differences in in vitro lymphocyte proliferation and priming of anti-KLH IgG production. These changes demonstrated that oral tolerance can occur in the T cell compartment in humans after a short course of antigen feeding. In contrast, those volunteers immunised with OVA showed no in vitro lymphocyte proliferation or DTH responses. Anti-OVA IgA and IgA were detectable in low levels prior to immunisation but there was no increase in humoral response after immunisation. These results suggest that oral tolerance is more pronounced to an antigen that has been encountered over prolonged periods. The nature of the tolerance to KLH is not known. It may be the result of the induction of immunoregulatory cells or the induction of clonal anergy. Experiments were designed to test for the presence of immunoregulatory cells induced by feeding KLH, but no positive results were obtained. The mechanisms maintaining tolerance to OVA are likewise unknown. Attempts to demonstrate clonal anergy by reserving tolerance with IL-2 failed.
Style APA, Harvard, Vancouver, ISO itp.
2

Rowsell, Paul. "Oral tolerance and immune mechanisms in food-induced diabetes". Thesis, University of Ottawa (Canada), 1996. http://hdl.handle.net/10393/9599.

Pełny tekst źródła
Streszczenie:
Diet controls $\sim$80% of type-I (insulin-dependent) diabetes in the diabetes-prone BioBreeding (BBdp) rat. This study was designed to define the relationship among diet, the gut immune system and the pancreas. BB rats were fed either a diabetogenic NIH-07 (NIH) diet or the diabetes protective, hydrolysed casein (HC) diet. Bovine serum albumin (BSA), ovalbumin (OVA), sheep red blood cells (SRBC) and NIH were given by gavage daily for 5 days. Both BBdp and the diabetes resistant BBc rat when fed NIH became unresponsive in antibody production to NIH antigens. None of the other oral antigen treatments induced tolerance. In delayed-type hypersensitivity (DTH) reactions, footpad injection of NIH resulted in lower DTH reactions and less increase in popliteal lymph node weight when animals were fed NIH than HC. We conclude that oral tolerance, both cell-mediated and humoral, to diabetogenic antigens is inducible in both strains of BB rats. This required daily feeding unlike in other rat strains. The depressed DTH reaction in the animals fed NIH indicates no link between the systemic Th1 DTH reaction to NIH and the Th1 food-induced diabetogenesis. Neonatal intrathymic injection of autoclaved NIH did not affect diabetes incidence, suggesting systemic exposure to these food antigens was not protective. Feeding neonatal BBdp rats a diabetogenic diet between 4 and 7d of age significantly delayed diabetes and reduced incidence. This effect was seen with the NIH diet and its diabetogenic component, wheat gluten. We conclude that early exposure to food diabetogens is protective against food-induced diabetes, indicating a crucial link between the local gut immune system and autoimmunity against pancreatic $\beta$ cells.
Style APA, Harvard, Vancouver, ISO itp.
3

Smith, Karen Margaret. "An investigation of oral tolerance and priming in vivo". Thesis, University of Glasgow, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269497.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Fuller, Kathleen Ann. "Oral tolerance in experimental autoimmune encephalomyelitis : the humoral arm /". The Ohio State University, 1990. http://rave.ohiolink.edu/etdc/view?acc_num=osu148767684711592.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Afuwape, Adeyemi Olutosin. "Oral tolerance and sensitisation : immunoregulation after feeding of ovalbumin and cow's milk". Thesis, University College London (University of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312961.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Harper, Helen Margaret. "The induction of immune responses in the murine small intestine". Thesis, University of Bristol, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.389589.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Dieti, Anastasia. "Influence of guar galactomannan on antigen absorption and induction of immunological oral tolerance". Thesis, King's College London (University of London), 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.433117.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Meyer, Abbie L. "Oral tolerance to myelin basic protein in mice : suppression of experimental autoimmune encephalomyelitis /". The Ohio State University, 1996. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487934589975749.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Rider, Kelly N. "Examination of the effect of reduction of probiotic species Lactobacillus due to broad spectrum antibiotic treatment on oral tolerance". Muncie, Ind. : Ball State University, 2009. http://cardinalscholar.bsu.edu/442.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

McGarry, Robert Gerard. "Modelling insulin/glucose dynamics and application to the analysis of oral glucose tolerance tests". Thesis, Queen's University Belfast, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.335562.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Oral tolerance"

1

Morteau, Olivier. Oral tolerance: The response of the intestinal mucosa to dietary antigens. Georgetown, TX: Landes Bioscience, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Morteau, Olivier. Oral tolerance: The response of the intestinal mucosa to dietary antigens. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Morteau, Olivier. Oral tolerance: The response of the intestinal mucosa to dietary antigens. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

D, Matthews Dawn, red. Diabetes sourcebook: Basic consumer health information about Type 1 diabetes (insulin-dependent or juvenile-onset diabetes), Type 2 diabetes (noninsulin-dependent or adult-onset diabetes, gestational diabetes, impaired glucose tolerance (IGT), and related complications, such as amputation, eye disease, gum disease, nerve damage, and end-stage renal disease : including facts about insulin, oral diabetes medications, blood sugar testing, and the role of exercise and nutrition in the control of diabetes : along with a glossary and resources for further help and information. Wyd. 3. Detroit, Mich: Omnigraphics, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Alexieiwcz, Tomasz. Walka tolerancja dialog współpraca: Wobec sekt i nowych ruchów religijnych : zapis sympozjum przygotowanego przez Dominkański Ośrodek Informacji o Sektach i Nowych Ruchach Religijnych w Warszawie oraz Kolegium Filozoficzno-Teologiczne Polskiej Prowincji Dominikanów w Warszawie, 17 marca 2004 roku. [Poznań]: IW Jerozolima, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Oral tolerance: Mechanisms and applications. New York, N.Y: New York Academy of Sciences, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Morteau, Olivier. Oral Tolerance: The Response of the Intestinal Mucosa to Dietary Antigens. Springer, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

(Editor), Howard L. Weiner, i Lloyd F. Mayer (Editor), red. Oral Tolerance: Mechanisms and Applications (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

(Editor), Howard L. Weiner, Lloyd F. Mayer (Editor) i Warren Strober (Editor), red. Oral Tolerance: New Insights and Prospects for Clinical Application (Annals of the New York Academy of Sciences). New York Academy of Sciences, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Weiner, Howard L. Oral Tolerance: Mechanisms and Applications (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Oral tolerance"

1

Weiner, Howard L. "Oral Tolerance". W Therapeutic Immunosuppression, 159–82. Dordrecht: Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0765-8_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Klimov, Vladimir V. "Food Allergies and Oral Tolerance". W Textbook of Allergen Tolerance, 185–215. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-04309-3_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Jensen, Chad D., Amy F. Sato, Elissa Jelalian, Elizabeth R. Pulgaron, Alan M. Delamater, Chad D. Jensen, Amy F. Sato i in. "Oral Glucose Tolerance Test (OGTT)". W Encyclopedia of Behavioral Medicine, 1389. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_769.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Varshney, Pooja, i A. Wesley Burks. "Oral Tolerance and Eosinophilic Esophagitis". W Eosinophilic Esophagitis, 339–50. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-515-6_26.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Carrillo, Adriana. "Oral Glucose Tolerance Test (OGTT)". W Encyclopedia of Behavioral Medicine, 1567. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_769.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Wildner, G., i S. R. Thurau. "Oral Tolerance in Autoimmune Uveitis". W Uveitis Update, 67–76. Basel: KARGER, 1999. http://dx.doi.org/10.1159/000060757.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Murch, S. "Oral Tolerance and Gut Maturation". W Nestl� Nutrition Workshop Series: Pediatric Program, 133–51. Basel: KARGER, 2004. http://dx.doi.org/10.1159/000077647.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Czerkinsky, C., J. B. Sun i J. Holmgren. "Oral Tolerance and Anti-Pathological Vaccines". W Defense of Mucosal Surfaces: Pathogenesis, Immunity and Vaccines, 79–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59951-4_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Jain, Aakanchha, Richa Jain i Sourabh Jain. "To Perform Oral Glucose Tolerance Test". W Basic Techniques in Biochemistry, Microbiology and Molecular Biology, 211–12. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-4939-9861-6_48.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Fuhrmann, K. "Targets in Oral Glucose Tolerance Testing". W Carbohydrate Metabolism in Pregnancy and the Newborn · IV, 227–37. London: Springer London, 1989. http://dx.doi.org/10.1007/978-1-4471-1680-6_20.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Oral tolerance"

1

Popov, Sergey V., Pavel A. Markov, Ida R. Nikitina, Raisa G. Ovodova i Yury S. Ovodov. "EFFECTS OF PLANT POLYSACCHARIDES ON PHAGOCYTES AND ORAL TOLERANCE". W XXIst International Carbohydrate Symposium 2002. TheScientificWorld Ltd, 2002. http://dx.doi.org/10.1100/tsw.2002.674.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Perpi�an, Gilberto, Erika Severeyn, Sara Wong i Miguel Altuve. "Nonlinear Heart Rate Variability Measures During the Oral Glucose Tolerance Test". W 2017 Computing in Cardiology Conference. Computing in Cardiology, 2017. http://dx.doi.org/10.22489/cinc.2017.148-302.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Quintero, Lersi, Gilberto Perpinan, Erika Severeyn, Miguel Altuve i Sara Wong. "Nonlinear parameters of heart rate variability during oral glucose tolerance test". W 2016 XXI Symposium on Signal Processing, Images and Artificial Vision (STSIVA). IEEE, 2016. http://dx.doi.org/10.1109/stsiva.2016.7743303.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Dritsas, Elias, Sotiris Alexiou, Ioannis Konstantoulas i Konstantinos Moustakas. "Short-term Glucose Prediction based on Oral Glucose Tolerance Test Values". W 15th International Conference on Health Informatics. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0010974200003123.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Kawakami, Hidenori, Toshiyuki KOYA, Yosuke Kimura, Cristiane Yamabayashi, Toshiki Furukawa, Takuro Sakagami, Hiroshi Kagamu, Takashi Hasegawa, Eiichi Suzuki i Ichiei Narita. "IL-17 Eliminates Therapeutic Effects Of Oral Tolerance In Murine Airway Allergic Inflammation". W American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4394.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

González-Domínguez, Raúl, Álvaro González-Domínguez i Alfonso Lechuga-Sancho. "Comparison of the metabolomic signature of diabetes and the oral glucose tolerance test". W 4th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2018. http://dx.doi.org/10.3390/ecmc-4-05571.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

NAKAYA, A., H. HISHIGAKI i S. MORISHITA. "MINING THE QUANTITATIVE TRAIT LOCI ASSOCIATED WITH ORAL GLUCOSE TOLERANCE IN THE OLETF RAT". W Proceedings of the Pacific Symposium. WORLD SCIENTIFIC, 1999. http://dx.doi.org/10.1142/9789814447331_0035.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

DeLeo, Jim, Carl Leonard i Anne E. Sumner. "Constructing clinical scoring systems to determine the need for an oral glucose tolerance test". W 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta). IEEE, 2009. http://dx.doi.org/10.1109/ijcnn.2009.5178936.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Chierici, Marco, Gianluigi Pillonetto, Gianna Toffolo i Claudio Cobelli. "Glucose Production by Deconvolution in Intravenous and Oral Glucose Tolerance Tests: Role of Output Variable". W Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.259961.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Chierici, Marco, Gianluigi Pillonetto, Gianna Toffolo i Claudio Cobelli. "Glucose Production by Deconvolution in Intravenous and Oral Glucose Tolerance Tests: Role of Output Variable". W Conference Proceedings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE, 2006. http://dx.doi.org/10.1109/iembs.2006.4398587.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Oral tolerance"

1

Chatila, Talal. Mechanisms of Oral Tolerance Breakdown in Food Allergy. Fort Belvoir, VA: Defense Technical Information Center, październik 2013. http://dx.doi.org/10.21236/ada602791.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Li, Yaodong, Zuoqiong Zhou, Yiping WANG, Gang MAI, Yangyun HANG, Lingling ZHU, Ming ZHAO i in. Comparison of oral sodium phosphate tablets and polyethylene glycol lavage solution for colonoscopy preparation: A systematic review and meta-analysis of randomized clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2023. http://dx.doi.org/10.37766/inplasy2023.5.0013.

Pełny tekst źródła
Streszczenie:
Review question / Objective: To systematically compare the bowel cleaning ability, patient tolerance and safety of oral sodium phosphate tablets (NaPTab) and oral polyethylene glycol electrolyte lavage solution (PEGL) to inform clinical decision making. Review question include: 1) patient populations with an indication for colonoscopy, including outpatients or inpatients requiring diagnosis or treatment, 2) randomized controlled trial (RCT) study designs, 3) a sodium phosphate tablet intervention group, 4) a control group receiving PEGL administered orally or by nasogastric tube, and 5) outcome measures including cleansing quality, adverse effects, patient acceptance, and changes in serum electrolytes after preparation.
Style APA, Harvard, Vancouver, ISO itp.
3

Field, Kevin, Maxim Gussev i Yukinori Yamamoto. FY-13 FCRD Milestone M3FT-13OR0202311 Weldability of ORNL Accident Tolerant Fuel Cladding Model Alloys For Thin Walled Tubes. Office of Scientific and Technical Information (OSTI), lipiec 2013. http://dx.doi.org/10.2172/1149392.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Bell, Gary L., Mark Christopher Vance, Kurt A. Terrani, Lance Lewis Snead i Chunghao Phillip Shih. The Production Process, Thermophysical Properties, and Quality Assurance Process for the Provision of Enhanced Accident Tolerant Fuels: ORNL Rodlets for the ATR ATF-1 Experiment. Office of Scientific and Technical Information (OSTI), październik 2013. http://dx.doi.org/10.2172/1105930.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Saldanha, Ian J., Gaelen P. Adam, Ghid Kanaan, Michael L. Zahradnik, Dale W. Steele, Valery A. Danilack, Alex Friedman Peahl, Kenneth K. Chen, Alison M. Stuebe i Ethan M. Balk. Postpartum Care up to 1 Year After Pregnancy: A Systematic Review and Meta-Analysis. Agency for Healthcare Research and Quality (AHRQ), czerwiec 2023. http://dx.doi.org/10.23970/ahrqepccer261.

Pełny tekst źródła
Streszczenie:
Objectives. This systematic review assesses postpartum care for individuals up to 1 year after pregnancy. We addressed two Key Questions (KQs) related to the comparative effectiveness and harms of: (1) alternative strategies for postpartum healthcare delivery and (2) extension of postpartum health insurance coverage. Data sources and review methods. We searched Medline®, Embase®, Cochrane CENTRAL, CINAHL®, and ClinicalTrials.gov from inception to November 16, 2022, to identify comparative studies in the United States and Canada (for KQ 1) and in the United States (for KQ 2). We extracted study data into the Systematic Review Data Repository Plus (SRDR+; https://srdrplus.ahrq.gov). We assessed the risk of bias and evaluated the strength of evidence (SoE) using standard methods. The protocol was registered in PROSPERO (registration number CRD42022309756). Results. We included 50 randomized controlled trials (RCTs) and 14 nonrandomized comparative studies (NRCSs) for KQ 1 and 28 NRCSs for KQ 2. Risk of bias was moderate to high for most RCTs and all NRCSs. KQ 1: Regarding where healthcare is provided, for general postpartum care (6 studies), whether the visit is at home/by telephone or at the clinic may not impact depression or anxiety symptoms (low SoE). For breastfeeding care (8 studies), whether the initial visit is at home or at the pediatric clinic may not impact depression symptoms up to 6 months postpartum, anxiety symptoms up to 2 months, hospital readmission up to 3 months (summary relative risk [RR] 1.38, 95% confidence interval [CI] 0.90 to 2.13; 4 studies), or other unplanned care utilization up to 2 months (low SoE, all outcomes). Regarding how care is provided, for general postpartum care (4 studies), integration of care (i.e., care provided by multiple types of providers) may not impact depression symptoms or substance use up to 1 year (low SoE). Regarding when care is provided, for contraceptive care (9 studies), compared with later contraception, earlier contraception start is probably associated with comparable continued IUD use at 3 and 6 months but greater implant use at 6 months (summary RR 1.36, 95% CI 1.13 to 1.64; 2 RCTs) (moderate SoE). Regarding who provides care, for breastfeeding care (19 studies), compared with no peer support, peer support is probably associated with higher rates of any breastfeeding at 1 month (summary effect size [ES] 1.13, 95% CI 1.03 to 1.24; 4 studies) and 3 to 6 months (summary ES 1.22, 95% CI 1.06 to 1.41; 4 studies) and of exclusive breastfeeding at 1 month (summary ES 1.10, 95% CI 1.02 to 1.19; 6 studies) but probably yields comparable rates of exclusive breastfeeding at 3 months and nonexclusive breastfeeding at 1 and 3 months (all moderate SoE). Compared with no lactation consultant, breastfeeding care by a lactation consultant is probably associated with higher rates of any breastfeeding at 6 months (summary ES 1.43, 95% CI 1.07 to 1.91; 3 studies) but not at 1 month or 3 months (all moderate SoE). Lactation consultant care may not be associated with rates of exclusive breastfeeding at 1 or 3 months (moderate SoE). Regarding coordination/management of care, provision of reminders for testing is probably associated with greater adherence to oral glucose tolerance testing up to 1 year postpartum but not random glucose testing or hemoglobin A1c testing (moderate SoE). Regarding use of information or communication technology (IT; 8 studies), IT use for breastfeeding care is probably associated with comparable rates of any breastfeeding at 3 months and 6 months and of exclusive breastfeeding at 3 months (all moderate SoE). Because of sparse evidence, inconsistent results, and/or the lack of reporting of prioritized outcomes, no conclusions related to interventions targeting healthcare providers are feasible (4 studies). KQ 2: Regarding health insurance (28 studies), more comprehensive health insurance is probably associated with greater attendance at postpartum visits (moderate SoE) and may be associated with fewer preventable readmissions and emergency room visits (low SoE). Conclusion. Most studies included in this systematic review enrolled predominantly healthy postpartum individuals. Researchers should therefore design studies that, either entirely or in part, enroll individuals at high risk of postpartum complications due to chronic conditions, pregnancy-related conditions, or incident or newly diagnosed conditions. New high-quality research is needed, especially for interventions targeting healthcare providers and the impact of more comprehensive or extended health insurance on postpartum health. Patient-reported outcomes, such as quality of life, should also be reported. Researchers should report separate data for various population subgroups, which could help close gaps in health outcomes among the races of postpartum individuals in the United States.
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Oral tolerance” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii